RT @DrMiniDey: Safety profile of #upadacitinib in #RA, #PsA, #AnkylosingSpondylitis ðð¼AE rates similar across UPA
Tweet Content
Safety profile of #upadacitinib in #RA, #PsA, #AnkylosingSpondylitis
👉🏼AE rates similar across UPA, ADA & MTX in RA, and UPA & ADA in PsA
👉🏼No new safety risks with long-term use
👉🏼#Herpeszoster & incr CPK more common w/ UPA vs ADA/MTX
Abs#1691 #ACR21 @RheumNow https://t.co/tKYi65kB5r
Show on Archive Page
On
Display in Search Results
On
PDQ
Off